Objective: In cancer screening programs, performing appropriate further work-up is essential. In order to elucidate whether the further work-up for the subjects with positive screening results by sputum cytology was performed appropriately, the present study was conducted as the first large-scale thorough survey in Japan. Methods: All of the lung cancer screening records from 2007 to 2012 in Ishikawa Prefecture were reviewed. Additional investigations about the further work-up were performed. Results: In total, 2 234 984 people were invited to undergo lung cancer screening, and 494 424 people participated in the screening. Of these, 25 264 people underwent sputum cytology, and 68 positive cases were identified. Three of these 68 cases did not undergo further work-up, and another three cases had already been diagnosed to have lung cancer. Forty-five of the remaining 62 cases did not have suspicious chest shadows, and bronchoscopic examinations were performed in 36 cases. Seventeen of these 36 cases were diagnosed as having cancer, whereas none of the nine cases who did not receive the examination was diagnosed (P = 0.038). A bronchoscopic examination was not performed due to other medical conditions in three cases, due to the patient's refusal in another three cases and in the remaining three cases, the reasons were unknown. Conclusion: The participation rate for further work-up was very high. However, there are some issues to be resolved regarding the transmission of information. With our new registered hospital system, the quality assurance of our screening program will be improved.
Introduction
In cancer screening programs, appropriate quality assurance is essential. In particular, performing appropriate further work-up is one of the most critical issues to ensure that patients receive the correct diagnosis and treatment.
In Japan, mass screening for tuberculosis using chest roentgenography had been widely performed since the 1950s. In 1982, population-based annual lung cancer screening, using chest roentgenography for all residents 40 years of age and older, and additional sputum cytology for smokers 50 years of age and older with a history of 30 pack-years or more, was introduced under the Health and Medical Services Law for the Aged (1) . The population-based screening involves two types of screening programs. One type is residence-based screening, which is performed mainly in rural areas, with a company commissioned to conduct the screening. Chest roentgenograms are taken in a bus, which was specially made for mass screening, with indirect exposure and miniature films. The other type is clinic-based screening. This is performed mainly in urban areas by regional clinics and hospitals. Chest roentgenograms are taken at a hospital or a clinic with direct exposure and standard films. In the 1990-2000s, several case-control studies were conducted and proved the efficacy of lung cancer screening in Japan (2) (3) (4) (5) (6) (7) (8) , and, therefore, the screening program has been continued.
For the quality control of the screening program, a Prefectural Committee for Management of the Cancer Screening System (PCMCSS) was established in each prefecture (9) . The Lung Cancer Screening Division (LCSD) of the Ishikawa PCMCSS collects the results of further work-up for the subjects with positive screening results through each municipality every year, and investigates annually the details of a given diagnosis in some cases where there are some possibility to have problems during the further work-up process.
According to the collected data until 2013, almost all subjects with positive screening results by chest roentgenography underwent chest computed tomography (CT), whereas some subjects with positive screening results by sputum cytology did not undergo a bronchoscopic examination. It is obvious that roentgenologically occult lung cancer cannot be detected without a bronchoscopic examination (10) (11) (12) (13) (14) . In order to elucidate whether the further work-up for the subjects with positive screening results by sputum cytology was performed appropriately, the LCSD decided to conduct the present survey about the work-up in Ishikawa Prefecture, Japan. In English literature, this report was the first report describing the results of a large-scale thorough survey, which was conducted to evaluate the quality assurance of further work-up for screenees with positive sputum cytology in population-based lung cancer screening in Japan.
Patients and methods
All of the screening records of subjects who participated in the population-based lung cancer screening from 2007 to 2012 in Ishikawa Prefecture were reviewed. In this survey, 'positive' was defined as the category which required further examination of the screenee (Category D and E). The subjects with positive sputum cytology findings were selected for further study, and the reports of further work-up in these subjects were then reviewed. The final diagnosis of these subjects and the examinations performed for further work-up were also investigated. When the reports were insufficient, additional inquiries were implemented involving the public health nurses of the municipality and/or the doctors in the hospitals where the further work-up had been performed.
The survey was conducted as one of the exemptions (survey for the quality control of cancer screening) of the Personal Information Protection Law, which was enacted in the Law itself, also obeying the guidelines of the Ministry of Health, Labour and Welfare of Japan. The differences in the frequencies between two groups were evaluated using the χ 2 test, and a value of P < 0.05 was considered to be statistically significant. ). There were 68 cases with positive sputum cytology findings (0.27% of all subjects who underwent the sputum cytology screening), and there were no significant differences according to the year of the screen (P > 0.1). Table 2 shows the characteristics of these 68 positive cases. Of the 68 cases, 63 (92.6%) were male, and only five cases were female. Although most of the positive cases were 60-79 years old, there were six cases 80 years-of-age or older. There were more positive cases in the clinic-based screening than in the residence-based screening. Twenty-five percent of these cases with positive sputum cytology were also positive for signs of possible cancer based on the interpretation of the chest roentgenogram taken at the same screening visit.
Results
As shown in Table 3 , three of these 68 cases (4.4%) did not visit a clinic/hospital for further work-up, and there were another three cases who had already been diagnosed to have lung cancer before the screening visit. Of the remaining 62 cases, 55 patients (88.7%) Table 4 . Chest CT was performed in all patients, whereas a bronchoscopic examination was performed in nine of these cases (56.3%). A diagnosis of lung cancer was made in all cases where a bronchoscopic examination was performed. However, in the seven cases where a bronchoscopic examination was not performed, the diagnoses were primary lung cancer in three cases, metastatic lung cancer in one case, and the definitive diagnosis was not obtained in the remaining three cases. Two of the three indeterminate cases (Cases 14 and 15) were 90 years old, and further workup was considered to be impossible for these cases. The remaining case (Case 16) was 68 years old male. By the annual check at the end of the year, the LCSD noticed that this patient was diagnosed as indeterminate without bronchoscopic examination, and thus the LCSD investigated the work-up process of him.
According to the investigation, he visited a regional small hospital for further work-up for the positive result of the lung cancer screening. He also had an abnormal shadow on his screening chest roentgenogram which was suspected to be lung cancer. However, a chest CT conducted at the hospital revealed that the shadow was not lung cancer, but old inflammatory changes. The doctor in charge falsely determined that he did not have lung cancer.
After this investigation, the LCSD asked to the public health nurse that she would advise the patient to visit another hospital which the LCSD recommended. The patient therefore visited the hospital and underwent a bronchoscopic examination, thus resulting in a final diagnosis of double early squamous cell carcinomas of hilar type. Thereafter, the patient underwent appropriate therapy.
The remaining 46 cases did not have suspicious shadows on their screening chest roentgenograms (Table 5 ). In these cases, CT was performed in 39 cases (84.8%). Thirteen of these 39 cases were diagnosed to have cancer, whereas four of the seven cases who did not undergo the CT scans were diagnosed with lung cancer. No significant difference was observed in this ratio (cases who were diagnosed with cancer/all cases) between the cases with CT and those without CT (13/39 = 33.3 vs. 4/7 = 57.1%, P > 0.1). On the other hand, a bronchoscopic examination was performed in 36 of 46 cases (78.3%), and was not performed in 10 cases. One of these 10 cases (Case 53) was revealed to have a pulmonary shadow by chest CT taken at a hospital, and was diagnosed to have lung cancer. Abnormal pulmonary shadows were not detected in the remaining nine cases. Seventeen of the 36 cases who received a bronchoscopic examination were diagnosed to have cancer, whereas none of nine cases who did not undergo a bronchoscopic examination was diagnosed to have cancer. The ratio (cases who were diagnosed with cancer/all cases) in the cases evaluated with bronchoscopic examination was significantly higher than that in cases without bronchoscopic examination (17/36 = 47.2 vs. 0/9 = 0%, P = 0.038). For the nine cases without abnormal chest shadows who did not receive a bronchoscopic examination, the reasons why the bronchoscopic examination was not performed were investigated by an additional inquiry and review of the medical records (Table 5 ). Pulmonologists were present at all of the hospitals they visited. CT was carried out in all patients. Bronchoscopic examinations were not performed due to the medical conditions in three cases, due to patient's refusal in another three cases, and the reasons were unknown in the other three cases despite the thorough survey.
Discussion
Although two randomized trials (11, 12) failed to prove the effectiveness of sputum cytology as lung cancer screening, some reports (14, 15) have indicated the possibility of mild effectiveness. In Japan, four case-controls studies (3-6) revealed the statistically significant efficacy of lung cancer screening including sputum cytology, so sputum cytology is included in Japanese lung cancer screening system. Since some patients with positive sputum cytology have abnormal shadows behind normal structures, such as diaphragm, CT should be performed for sputum-positive cases. However, the target of sputum cytology is early hilar lung cancer without abnormal chest shadows, and a bronchoscopic examination is indispensable for sputumpositive cases.
Three previously diagnosed lung cancer patients participated in the mass screening for lung cancer, which was a waste of resources. It will be necessary to provide better explanations in the invitation flyers or letters for the mass screening to avoid having patients who already have a diagnosis from undergoing the screening.
The participation rate for further work-up was very high (62/65; 95.4%), but three people still did not undergo further work-up. Since the positive predictive value of sputum cytology is extremely high, it was possible that at least one of these subjects had lung cancer. All three people lived in urban areas, and implementing measures to ensure that such patients visit hospitals to undergo further evaluations is important.
Six of the subjects were 80 years of age or older. Furthermore, two of the subjects were 90 years old, and they did not receive bronchoscopic examinations. In Japan, there is no upper age limit for the subjects participating in cancer screening programs at present, but this should be reconsidered from the viewpoint of 'harm'. For very elderly people, screening might bring more harm than benefit.
There were nine subjects who did not receive bronchoscopic examinations and were not diagnosed as having cancer. Since 47.2% of patients who received bronchoscopic examinations were diagnosed to have cancer, it is likely that four of these nine people might have been diagnosed if they had received a bronchoscopic examination. The positive predictive value of sputum cytology in this series was very high, at nearly 50%, so a longer and more detailed follow-up should be recommended even if a patient refuses to undergo a subsequent bronchoscopic examination. Moreover, sufficient information about further work-up for screening-positive cases should be provided to all screenees at their screening visit.
There were several possibilities for the mistaken diagnosis of Case 16. The doctor in charge may not have known that the case had not only positive results by chest roentgenography, but also by sputum cytology, or the doctor may not have known that the cases with positive sputum cytology should receive a bronchoscopic examination to detect early central bronchogenic carcinoma, because small regional hospitals did not always have a pulmonologist on staff. This case was considered to indicate that the system for disseminating information should be improved. For the purpose, our screening program has used a special request letter for further work-up for patients with positive sputum cytology since 2013.
Despite this detailed survey, the reasons why three patients did not receive bronchoscopic examinations were unknown. This also suggested that the collection of information should be improved. In 2013, our screening program adopted a registered hospital system for further work-up of patients with positive sputum cytology findings. The hospitals which intend to diagnose patients with positive sputum cytology can apply to register for this system. In order to be registered, there are several requirements that must be met, such as that a certified bronchoscopist works at the hospital at least one day a week. The hospital then must submit a report about the further work-up to the LCSD of Ishikawa PCMCSS.
Conclusions
Although the participation rate for further work-up in Ishikawa Prefecture was very high, there might be some cases who were not diagnosed as having cancer due to not undergoing a bronchoscopic examination. Transmission of information in our screening system also had some problems to be solved, and the new registered hospital system implemented in 2013 may improve the quality assurance of our screening program. The survey also revealed that the Japanese lung cancer screening system had several issues to be resolved, such as the upper age limit of the screenees, and the national policy should be changed in the near future.
